Paolo Gaibani
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 161 publications
Emergent Sulbactam-Durlobactam Non-Susceptibility in Acinetobacter baumannii: Potential Interplay Between PBP3 and AdeFGH Overexpression.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 28, 2026
In vitro interactions of thymol in combination with antimicrobials against carbapenem-resistant Acinetobacter baumannii and multidrug-resistant Klebsiella pneumoniae clinical isolates.
Journal: The new microbiologica
Published: July 27, 2026
Case Commentary: When susceptibility is not enough in recurrent Burkholderia cenocepacia infection.
Journal: Antimicrobial agents and chemotherapy
Published: May 28, 2026
Synergistic activity of cefepime/enmetazobactam with meropenem, piperacillin, piperacillin/tazobactam, cefiderocol and fosfomycin against Klebsiella pneumoniae carrying blaKPC allelic variants.
Journal: The Journal of antimicrobial chemotherapy
Published: April 12, 2026
Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring.
Journal: JAC-antimicrobial resistance
Published: March 20, 2026
Synergistic Activity of Eugenol, Cinnamaldehyde, and Carvacrol in Combination with Different Antibacterial Agents Against Multidrug-Resistant Gram-Negative Clinical Isolates.
Journal: Antibiotics (Basel, Switzerland)
Published: March 13, 2026
In vitro activity of cefepime/zidebactam against Klebsiella pneumoniae carrying bla KPC variants conferring resistance to ceftazidime/avibactam.
Journal: JAC-antimicrobial resistance
Published: March 04, 2026
Emergence of dalbavancin non-susceptible methicillin-resistant Staphylococcus epidermidis (MRSE) in a patient treated with dalbavancin prolonged therapy: Case report, therapeutic drug monitoring and genomic characterization.
Journal: International journal of antimicrobial agents
Published: February 24, 2026
Cefepime Combined with Late-Generation β-Lactamase Inhibitors: Mechanisms of Action, In Vitro Activity, PK/PD Characteristics, Clinical Evidence and Resistance Mechanisms.
Journal: Antibiotics (Basel, Switzerland)
Published: February 16, 2026
Epidemiology and Molecular Characterization of Mycoplasmosis in Northeastern Part of Italy, 2023.
Journal: Pathogens (Basel, Switzerland)
Published: February 09, 2026
Genome sequence of a methicillin-resistant Staphylococcus epidermidis (MRSE) resistant to dalbavancin and teicoplanin isolated in Italy, 2023.
Journal: Journal of global antimicrobial resistance
Published: February 03, 2026
Characterization of prophage carrying blaKPC-184 in a ST307 Klebsiella pneumoniae clinical isolate from Italy.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: January 10, 2026
Last Updated: 09/26/2026